RIA
JAZZ icon

RPG Investment Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History

RPG Investment Advisory’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,155
Closed -$1.3M – 275
2019
Q3 		$1.3M Sell
10,155
-353
-3% -$47.3K 0.31% 68
2019
Q2 		$1.5M Sell
10,508
-1,452
-12% -$195K 0.35% 68
2019
Q1 		$1.71M Sell
11,960
-568
-5% -$74.1K 0.4% 70
2018
Q4 		$1.55M Sell
12,528
-557
-4% -$82.6K 0.39% 73
2018
Q3 		$2.2M Sell
13,085
-2,250
-15% -$387K 0.46% 71
2018
Q2 		$2.64M Sell
15,335
-15,507
-50% -$2.53M 0.59% 66
2018
Q1 		$4.66M Sell
30,842
-469
-1% -$68.8K 1.06% 41
2017
Q4 		$4.22M Sell
31,311
-611
-2% -$84.7K 1.02% 41
2017
Q3 		$4.67M Sell
31,922
-11
-0% -$1.66K 1.19% 31
2017
Q2 		$4.97M Sell
31,933
-427
-1% -$65.3K 1.36% 23
2017
Q1 		$4.7M Sell
32,360
-232
-0.7% -$30.2K 1.37% 25
2016
Q4 		$3.55M Sell
32,592
-700
-2% -$78K 1.2% 33
2016
Q3 		$4.04M Sell
33,292
-2,934
-8% -$395K 1.26% 26
2016
Q2 		$5.12M Sell
36,226
-342
-0.9% -$50.4K 1.37% 21
2016
Q1 		$4.77M Buy
36,568
+32,986
+921% +$4.11M 1.84% 17
2015
Q4 		$503K Buy
+3,582
New +$496K 0.19% 79

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

RPG Investment Advisory's JAZZ Position: Q4 2019 in Review

RPG Investment Advisory sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2019, closing a stake of 10,155 shares — an estimated $1.3M sold.

RPG Investment Advisory first reported a position in JAZZ in Q4 2015 and held it in 16 quarters. The position peaked at $5.12M in Q2 2016. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

  • RPG Investment Advisory reported no remaining Jazz Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • RPG Investment Advisory sold 10,155 Jazz Pharmaceuticals shares in Q4 2019, an estimated $1.3M.
  • RPG Investment Advisory first reported a position in Jazz Pharmaceuticals in Q4 2015 and held it in 16 quarters.
  • RPG Investment Advisory's Jazz Pharmaceuticals position peaked at $5.12M in Q2 2016.
  • 446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on RPG Investment Advisory's 13F filing for Q4 2019, filed 7 Feb 2020.